CSPC Pharmaceutical Group Ltd - ESG Rating & Company Profile powered by AI
The ESG score covers seventeen UN Sustainable Development Goals including: 'Quality Education', 'Sustainable Cities & Communities' and 'Life below Water'. If you work at CSPC Pharmaceutical Group Ltd and you wish to licence your Sustainability aseessment, please contact us. This SDG rating for CSPC Pharmaceutical Group Ltd represents its transparency towards the United Nations SDGs.
CSPC Pharmaceutical Group Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.3; made up of an environmental score of 0.0, social score of 1.0 and governance score of 0.0.
0.3
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1952 | Tibet Rhodiola Pharmaceutical Holding Co | 0.4 | Low |
1952 | Tilray Inc | 0.4 | Low |
1967 | CSPC Pharmaceutical Group Ltd | 0.3 | Low |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does CSPC Pharmaceutical Group Ltd have an accelerator or VC vehicle to help deliver innovation?
Does CSPC Pharmaceutical Group Ltd disclose current and historical energy intensity?
Does CSPC Pharmaceutical Group Ltd report the average age of the workforce?
Does CSPC Pharmaceutical Group Ltd reference operational or capital allocation in relation to climate change?
Does CSPC Pharmaceutical Group Ltd disclose its ethnicity pay gap?
Does CSPC Pharmaceutical Group Ltd disclose cybersecurity risks?
Does CSPC Pharmaceutical Group Ltd offer flexible work?
Does CSPC Pharmaceutical Group Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does CSPC Pharmaceutical Group Ltd disclose the number of employees in R&D functions?
Does CSPC Pharmaceutical Group Ltd conduct supply chain audits?
Does CSPC Pharmaceutical Group Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does CSPC Pharmaceutical Group Ltd conduct 360 degree staff reviews?
Does CSPC Pharmaceutical Group Ltd disclose the individual responsible for D&I?
Does CSPC Pharmaceutical Group Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does CSPC Pharmaceutical Group Ltd disclose current and / or historical scope 2 emissions?
Does CSPC Pharmaceutical Group Ltd disclose water use targets?
Does CSPC Pharmaceutical Group Ltd have careers partnerships with academic institutions?
Did CSPC Pharmaceutical Group Ltd have a product recall in the last two years?
Does CSPC Pharmaceutical Group Ltd disclose incidents of discrimination?
Does CSPC Pharmaceutical Group Ltd allow for Work Councils/Collective Agreements to be formed?
Has CSPC Pharmaceutical Group Ltd issued a profit warning in the past 24 months?
Does CSPC Pharmaceutical Group Ltd disclose parental leave metrics?
Does CSPC Pharmaceutical Group Ltd disclose climate scenario or pathway analysis?
Does CSPC Pharmaceutical Group Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does CSPC Pharmaceutical Group Ltd disclose the pay ratio of women to men?
Does CSPC Pharmaceutical Group Ltd support suppliers with sustainability related research and development?
Does CSPC Pharmaceutical Group Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does CSPC Pharmaceutical Group Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is CSPC Pharmaceutical Group Ltd involved in embryonic stem cell research?
Does CSPC Pharmaceutical Group Ltd disclose GHG and Air Emissions intensity?
Does CSPC Pharmaceutical Group Ltd disclose its waste policy?
Does CSPC Pharmaceutical Group Ltd report according to TCFD requirements?
Does CSPC Pharmaceutical Group Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does CSPC Pharmaceutical Group Ltd disclose energy use targets?
Does CSPC Pharmaceutical Group Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does CSPC Pharmaceutical Group Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for CSPC Pharmaceutical Group Ltd
These potential risks are based on the size, segment and geographies of the company.
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, the Americas, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. It provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson's disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer. The company also offers Shuluoke, Nuomoling, Weihong, and Xinweihong for various infections; Xuanning for hypertension; Encun to prevent atherosclerotic thrombosis events; Qixiao to treat upper respiratory tract infection; Linmeixin and Shuanglexin for diabetes; Gubang and Gubangjia to treat osteoporosis in postmenopausal women; and Gaoshunsong for arthritis, osteoarthritis, ankylosing spondylitis, frozen shoulder, bursuitis, tenosynovitis, acute gout, dysmenorrhea, toothache and postoperative pain, low back pain, sprain, strain, and other soft tissue injuries. In addition, it provides Debixin for various ulcer; Qimaite for acute and chronic pains; antibiotics, vitamin C, and caffeine APIs; functional food and glucose products; and healthcare services. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the People's Republic of China.